Works matching IS 19466234 AND DT 2017 AND VI 9 AND IP 389

Results: 5

Matched preclinical designs for improved translatability.
Published in:
2017
By:
- Aittokallio, Tero;
- Scherer, Andreas;
- Poutanen, Matti;
- Freedman, Leonard P.
Publication type:
Editorial
Inhibiting the oncogenic translation program is an effective therapeutic strategy in multiple myeloma.
Published in:
Science Translational Medicine, 2017, v. 9, n. 389, p. 1, doi. 10.1126/scitranslmed.aal2668
By:
- Manier, Salomon;
- Huynh, Daisy;
- Yu J. Shen;
- Jia Zhou;
- Yusufzai, Timur;
- Salem, Karma Z.;
- Ebright, Richard Y.;
- Jiantao Shi;
- Jihye Park;
- Glavey, Siobhan V.;
- Devine, William G.;
- Chia-Jen Liu;
- Leleu, Xavier;
- Quesnel, Bruno;
- Roche-Lestienne, Catherine;
- Snyder, John K.;
- Brown, Lauren E.;
- Gray, Nathanael;
- Bradner, James;
- Whitesell, Luke
Publication type:
Article
Leukotriene B<sub>4</sub> antagonism ameliorates experimental lymphedema.
Published in:
Science Translational Medicine, 2017, v. 9, n. 389, p. 1, doi. 10.1126/scitranslmed.aal3920
By:
- Wen Tian;
- Rockson, Stanley G.;
- Xinguo Jiang;
- Kim, Jeanna;
- Begaye, Adrian;
- Shuffle, Eric M.;
- Tu, Allen B.;
- Cribb, Matthew;
- Nepiyushchikh, Zhanna;
- Feroze, Abdullah H.;
- Zamanian, Roham T.;
- Dhillon, Gundeep S.;
- Voelkel, Norbert F.;
- Peters-Golden, Marc;
- Kitajewski, Jan;
- Dixon, J. Brandon;
- Nicolls, Mark R.
Publication type:
Article
In vivo imaging reveals a tumor-associated macrophage-mediated resistance pathway in anti-PD-1 therapy.
Published in:
Science Translational Medicine, 2017, v. 9, n. 389, p. 1, doi. 10.1126/scitranslmed.aal3604
By:
- Arlauckas, Sean P.;
- Garris, Christopher S.;
- Kohler, Rainer H.;
- Kitaoka, Maya;
- Cuccarese, Michael F.;
- Yang, Katherine S.;
- Miller, Miles A.;
- Carlson, Jonathan C.;
- Freeman, Gordon J.;
- Anthony, Robert M.;
- Weissleder, Ralph;
- Pittet, Mikael J.
Publication type:
Article
Phenome-wide scanning identifies multiple diseases and disease severity phenotypes associated with HLA variants.
Published in:
Science Translational Medicine, 2017, v. 9, n. 389, p. 1, doi. 10.1126/scitranslmed.aai8708
By:
- Karnes, Jason H.;
- Bastarache, Lisa;
- Shaffer, Christian M.;
- Gaudieri, Silvana;
- Yaomin Xu;
- Glazer, Andrew M.;
- Mosley, Jonathan D.;
- Shilin Zhao;
- Raychaudhuri, Soumya;
- Mallal, Simon;
- Zhan Ye;
- Mayer, John G.;
- Brilliant, Murray H.;
- Hebbring, Scott J.;
- Roden, Dan M.;
- Phillips, Elizabeth J.;
- Denny, Joshua C.
Publication type:
Article

Works matching IS 19466234 AND DT 2017 AND VI 9 AND IP 389

Matched preclinical designs for improved translatability.

Inhibiting the oncogenic translation program is an effective therapeutic strategy in multiple myeloma.

Leukotriene B<sub>4</sub> antagonism ameliorates experimental lymphedema.

In vivo imaging reveals a tumor-associated macrophage-mediated resistance pathway in anti-PD-1 therapy.

Phenome-wide scanning identifies multiple diseases and disease severity phenotypes associated with HLA variants.